-
1
المؤلفون: Vanna Chiarion-Sileni, Paul Nathan, Axel Hauschild, Jeffrey J. Legos, Jacob Schachter, Mario Mandalà, Boguslawa Karaszewska, Jean-Jacques Grob, Caroline Dutriaux, Dirk Schadendorf, Daniil Stroiakovski, Michael A. Davies, Helen Gogas, John B. A. G. Haanen, Claus Garbe, Ying Zhang, Antoni Ribas, Piotr Rutkowski, Keith T. Flaherty, Georgina V. Long, Mathilde Kaper, Caroline Robert, Céleste Lebbé, Evgeny Levchenko, Bijoyesh Mookerjee, Andrzej Mackiewicz
مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Multivariate analysis, Combination therapy, Pyridones, Medizin, Pyrimidinones, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, medicine, Humans, Neoplasm Metastasis, Vemurafenib, Melanoma, Protein Kinase Inhibitors, Aged, Trametinib, L-Lactate Dehydrogenase, business.industry, MEK inhibitor, Imidazoles, Dabrafenib, Middle Aged, medicine.disease, Prognosis, Survival Analysis, Surgery, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4136aa0fa3f1e15c66017826608bb4b0Test
https://www.ncbi.nlm.nih.gov/pubmed/28648698Test -
2
المؤلفون: Stephen R. Lane, Michael A. Davies, Jean-Jacques Grob, Philippe Legenne, Antoni Ribas, Dirk Schadendorf, Caroline Robert, Carmen Mak, Paul Nathan, Georgina V. Long, Keith T. Flaherty
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Multivariate analysis, Pyridones, Medizin, Disease, Pyrimidinones, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, Overall survival, Medicine, Humans, Melanoma, Randomized Controlled Trials as Topic, Retrospective Studies, Trametinib, business.industry, Disease progression, Imidazoles, Dabrafenib, Retrospective cohort study, medicine.disease, Surgery, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Disease Progression, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044efee0647329ab4cd29a1b18d766adTest
https://www.ncbi.nlm.nih.gov/pubmed/27864013Test -
3
المؤلفون: Daniil Stroyakovskiy, Jochen Utikal, Keith T. Flaherty, Daniele Ouellet, Virginia Ferraresi, Michelle Casey, Claus Garbe, Axel Hauschild, V. Chiarion Sileni, Caroline Robert, Helen Gogas, Antoni Ribas, Michael Millward, Nadezhda Kovalenko, Jean-Jacques Grob, Jhangir G. Irani, Paul Nathan, Dirk Schadendorf, John B. A. G. Haanen, V. Probachai, Mario Mandalà, F. de Braud, Johan Hansson, Georgina V. Long, Igor Bondarenko, Kiran Patel, Ngocdiep T. Le, Anne-Marie Martin, James Larkin, Ana Arance, T. Jouary, Peter Mohr, Douglas J. DeMarini, Céleste Lebbé, Evgeny Levchenko
مصطلحات موضوعية: Adult, Male, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Fever, Pyridones, Medizin, Kaplan-Meier Estimate, Pyrimidinones, Gastroenterology, Disease-Free Survival, chemistry.chemical_compound, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, Carcinoma, medicine, Clinical endpoint, Humans, Melanoma, Aged, Mitogen-Activated Protein Kinase Kinases, Cobimetinib, Trametinib, business.industry, Hazard ratio, Imidazoles, Binimetinib, Dabrafenib, General Medicine, Middle Aged, medicine.disease, Surgery, chemistry, Mutation, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266d13e0581ba3c486d28c2d159ca1daTest
http://hdl.handle.net/11391/1480877Test -
4
المؤلفون: Keith T, Flaherty, Caroline, Robert, Peter, Hersey, Paul, Nathan, Claus, Garbe, Mohammed, Milhem, Lev V, Demidov, Jessica C, Hassel, Piotr, Rutkowski, Peter, Mohr, Reinhard, Dummer, Uwe, Trefzer, James M G, Larkin, Jochen, Utikal, Brigitte, Dreno, Marta, Nyakas, Mark R, Middleton, Jürgen C, Becker, Michelle, Casey, Laurie J, Sherman, Frank S, Wu, Daniele, Ouellet, Anne-Marie, Martin, Kiran, Patel, Dirk, Schadendorf, Mary, Richardson
المصدر: The New England journal of medicine. 367(2)
مصطلحات موضوعية: Oncology, Adult, Male, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Pyridones, Dacarbazine, MAP Kinase Kinase 2, Medizin, MAP Kinase Kinase 1, Antineoplastic Agents, Kaplan-Meier Estimate, Pyrimidinones, Disease-Free Survival, chemistry.chemical_compound, Young Adult, Internal medicine, medicine, Humans, Vemurafenib, Melanoma, Protein Kinase Inhibitors, Aged, Trametinib, Cobimetinib, Aged, 80 and over, business.industry, MEK inhibitor, Hazard ratio, Dabrafenib, General Medicine, Middle Aged, medicine.disease, Surgery, Intention to Treat Analysis, chemistry, Mutation, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778f247f586f7abe700c37ec7f75715aTest
http://ora.ox.ac.uk/objects/uuid:17a4cd0c-72ea-46f7-ab36-457c375b3557Test